BOSTON SCIENTIFIC CORPORATION ADVANTAGE SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
|
Back to Search Results |
|
Model Number M0068502000 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erosion (1750); Hemorrhage/Bleeding (1888); Dyspareunia (4505)
|
Event Date 11/16/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
Block b3 date of event: date of event was approximated to (b)(6) 2017, implant date, as no event date was reported.Block e1: this event was reported by the patient's legal representation.The implant surgeon is: dr.(b)(6).Block h6: imdrf patient codes e2006, e1405 and e0506 capture the reportable events of erosion of surgical mesh into the vagina, dyspareunia and postmenopausal vaginal bleeding.Imdrf impact code f1905 captures the reportable event of mesh excision surgery.
|
|
Event Description
|
It was reported to boston scientific corporation that an advantage system was implanted into the patient during a laparoscopic sacral colpopexy, cystocele repair + laparoscopic enterocele repair + retropubic midurethral sling using a boston scientific advantage system + cystoscopy procedure performed on (b)(6) 2017, for the treatment of prolapse of vaginal vault after hysteroscopy, lateral cystocele vaginal enterocele, rectocele, stress incontinence, stage 2 anterior vaginal wall prolapse, stage 2 posterior vaginal wall prolapse and stage 2 vaginal vault prolapse.The patient tolerated the procedure well.On (b)(6) 2022, the patient underwent excision of exposed surgical mesh and vaginal repair due to erosion of surgical mesh into the vagina.The patient presented with postmenopausal vaginal bleeding and dyspareunia.Pelvic exam revealed a 1cm area of exposed surgical mesh at the right apex corner of the vaginal cuff.There was an approximately 1cm linear area of mesh erosion into right side of the vaginal cuff at the apex.Only the portion of the exposed mesh was excised.The patient was woken up from anesthesia in stable condition.She will start vaginal estrogen therapy after discharge and follow up in one week.
|
|
Search Alerts/Recalls
|
|
|